Company news
PRF Technologies Ltd. news in 2024
PRF Technologies Ltd.'s news releases, calls and decks from 2024, newest first.
PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110
December 26, 2024
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
November 19, 2024
PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
November 6, 2024
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110
September 10, 2024
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds
September 9, 2024
PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study
August 19, 2024
PainReform Provides Business Update for the Second Quarter of 2024
August 14, 2024
PainReform Announces Development and Successful Manufacturing of New Formulations Providing Anti-Inflammatory and Extended Analgesic Effects
August 11, 2024
PainReform Announces Favorable Safety Profile of PRF-110, Indicating Potential for Use in New Surgical Applications Requiring Higher Doses
August 6, 2024
PainReform Ltd. Announces Favorable Wound Healing Data in Human Clinical Trials for PRF-110
August 4, 2024
PainReform’s New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room Temperature
July 31, 2024
PainReform Files Patent Covering Highly Scalable Manufacturing Process for PRF-110 Following Successful Completion and Testing
July 23, 2024
PainReform Completes Enrollment in the Second Part of its Phase 3 Bunionectomy Trial for PRF-110
June 25, 2024
PainReform Provides Business Update for the First Quarter of 2024
May 14, 2024
PainReform Advances Pain Relief Solution, PRF-110, in Phase 3 Trial to Combat Opioid Crisis
May 6, 2024
PainReform Announces Closing of $4 Million Public Offering
April 17, 2024
PainReform Announces Pricing of $4 Million Public Offering
April 15, 2024
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain Relief
January 2, 2024